Literature DB >> 29556980

GWAS-Supported CRP Gene Polymorphisms and Functional Outcome of Large Artery Atherosclerotic Stroke in Han Chinese.

Zusen Ye1,2, Hao Zhang3, Lingli Sun3, Huan Cai1, Yonggang Hao1, Zongliang Xu1, Zhizhong Zhang4, Xinfeng Liu5.   

Abstract

Elevated C-reactive protein (CRP) levels increase the risk of poor functional disability in patients with ischemic stroke (IS). This study aimed to investigate the association between CRP gene polymorphisms and 3-month functional disability of large artery atherosclerotic (LAA) stroke in Han Chinese. Patients with first-ever LAA IS were prospectively enrolled in Nanjing Stroke Registry Program between August 2013 and October 2015. Five single-nucleotide polymorphisms (SNPs) (rs876537, rs2794520, rs3093059, rs7553007 and rs11265260) in CRP gene related to CRP levels in Asian by genome-wide association study were genotyped. The functional outcome at 3 months after the index stroke was assessed by the modified Rankin scale. Associations between genotypes and functional outcome of LAA IS were analyzed with logistic regression model. A total of 690 eligible patients (507 males) were evaluated. SNPs rs11265260 (multivariate-adjusted, p = 0.022), rs2794520 (multivariate-adjusted, p = 0.036) and rs3093059 (multivariate-adjusted, p = 0.027) were significantly associated with elevated CRP in acute IS. Two SNPs, rs3093059 (dominant model: adjusted OR 2.49; 95% CI 1.55-4.00; recessive model: adjusted OR 3.67; 95% CI 1.22-11.03) and rs11265260 (dominant model: adjusted OR 2.51; 95% CI 1.56-4.02; recessive model: adjusted OR 4.70; 95% CI 1.63-13.56) independently predicted 3-month poor outcome of first-ever LAA IS, after adjusting for covariates. In addition, haplotype analysis indicated that haplotype GCTGC (adjusted OR 1.76; 95% CI 1.05-2.95; p = 0.031) increased the poor outcome risk. SNPs rs3093059 and rs11265260 in CRP gene may influence the 3-month functional outcome of first-ever LAA IS in Han Chinese.

Entities:  

Keywords:  C-reactive protein; Gene; Large artery atherosclerotic stroke; Polymorphism; Prognosis

Mesh:

Substances:

Year:  2018        PMID: 29556980     DOI: 10.1007/s12017-018-8485-y

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  38 in total

1.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

2.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper.

Authors:  Luigi M Biasucci
Journal:  Circulation       Date:  2004-12-21       Impact factor: 29.690

3.  C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome.

Authors:  K Rajeshwar; Subhash Kaul; Amal Al-Hazzani; M Sai Babu; N Balakrishna; Vandana Sharma; A Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 4.  What does minor elevation of C-reactive protein signify?

Authors:  Irving Kushner; Debra Rzewnicki; David Samols
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

5.  CRP gene polymorphism predicts post-stroke functional outcome in Han Chinese.

Authors:  J Guo; L Yu; J Zhang; N Chen; M Zhou; L He
Journal:  Acta Neurol Scand       Date:  2013-08-23       Impact factor: 3.209

Review 6.  The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy.

Authors:  T J DeGraba
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

Review 8.  C-reactive protein: the best laboratory indicator available for monitoring disease activity.

Authors:  S D Deodhar
Journal:  Cleve Clin J Med       Date:  1989 Mar-Apr       Impact factor: 2.321

9.  Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin.

Authors:  Kuo-Ho Yeh; Tzu-Hsien Tsai; Han-Tan Chai; Steve Leu; Sheng-Ying Chung; Sarah Chua; Yung-Lung Chen; Hung-Sheng Lin; Chun-Man Yuen; Hon-Kan Yip
Journal:  J Transl Med       Date:  2012-01-05       Impact factor: 5.531

10.  New variants including ARG1 polymorphisms associated with C-reactive protein levels identified by genome-wide association and pathway analysis.

Authors:  Nadimuthu Vinayagamoorthy; Hae-Jin Hu; Seon-Hee Yim; Seung-Hyun Jung; Jaeseong Jo; Sun Ha Jee; Yeun-Jun Chung
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

View more
  4 in total

1.  Integrating Multi-Omics Data to Identify Novel Disease Genes and Single-Neucleotide Polymorphisms.

Authors:  Sheng Zhao; Huijie Jiang; Zong-Hui Liang; Hong Ju
Journal:  Front Genet       Date:  2020-01-24       Impact factor: 4.599

Review 2.  Influences of genetic variants on stroke recovery: a meta-analysis of the 31,895 cases.

Authors:  Nikhil Math; Thang S Han; Irina Lubomirova; Robert Hill; Paul Bentley; Pankaj Sharma
Journal:  Neurol Sci       Date:  2019-07-29       Impact factor: 3.307

3.  Sex-specific and opposite modulatory aspects revealed by PPI network and pathway analysis of ischemic stroke in humans.

Authors:  Yan Lv; X Y He; Dongguo Li; Tao Liu; G Q Wen; Junfa Li
Journal:  PLoS One       Date:  2020-01-03       Impact factor: 3.240

Review 4.  Stroke Genomics: Current Knowledge, Clinical Applications and Future Possibilities.

Authors:  Sandeep Appunni; Muni Rubens; Venkataraghavan Ramamoorthy; Anshul Saxena; Peter McGranaghan; Emir Veledar
Journal:  Brain Sci       Date:  2022-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.